Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer
| dc.contributor.author | Tural, Deniz | |
| dc.contributor.author | Selçukbiricik, Fatih | |
| dc.contributor.author | Yıldız, Özcan | |
| dc.contributor.author | Elçin, Olgun | |
| dc.contributor.author | Erdamar, Sibel | |
| dc.contributor.author | Güney, Sabri | |
| dc.contributor.author | Demireli, Fuat | |
| dc.contributor.author | Büyükünal, Evin | |
| dc.contributor.author | Serdengeçti, Süheyla | |
| dc.date.accessioned | 10.07.201910:49:13 | |
| dc.date.accessioned | 2019-07-10T19:56:36Z | |
| dc.date.available | 10.07.201910:49:13 | |
| dc.date.available | 2019-07-10T19:56:36Z | |
| dc.date.issued | 2014 | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | |
| dc.description | WOS: 000343887400016 | |
| dc.description | PubMed ID: 24218281 | |
| dc.description.abstract | The study populations of previous preoperative chemoradiotherapy (pre-CRT) studies have consisted of mixed clinical stages, such as cT3-cT4 and/or cN positive. For this reason, it has not been possible to demonstrate whether pre-CRT is of benefit for individual subgroups. The medical records of 137 rectal cancer patients with clinical stage T3, N0 disease who received either pre-CRT or postoperative chemoradiotherapy (post-CRT) between 2002 and 2011 were retrospectively analyzed. The regimen of pre-CRT consisted of slow fluorouracil (5FU) infusion and that of post-CRT consisted of bolus 5FU and leucovorin concurrent with radiation. Following pre-CRT, significant downstaging was achieved. However, administration of pre-CRT did not influence the type of surgical resection in tumours a parts per thousand currency sign5 cm distant from the anal verge (p = 0.14). Pathological complete response was achieved in 16 % of the patients in the pre-CRT group. The local recurrence rate (LRR) at 5 years was 5.7 % in the pre-CRT and 11.1 % in the post-CRT groups (p = 0.04). The distant recurrence rate (DRR) at 5 years was 76 % and 77 % in the pre-CRT and post-CRT groups, respectively (p = 0.1). Overall survival was similar in two groups (74.8 % vs. 75.3 %, p = 0.3). The treatment of stage T3, N0 rectal cancer patients with pre-CRT followed by surgery decreased LRR, but did not improve DRR or OS as compared with surgery followed by post-CRT in our patient cohort. | |
| dc.identifier.citation | Tural, D., Selçukbiricik, F., Yıldız, Ö., Elçin, O., Erdamar, S., Güney, S. ... Serdengeçti, S. (2014). Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer. International Journal of Clinical Oncology, 19(5), 889-896. | |
| dc.identifier.doi | 10.1007/s10147-013-0636-4 | |
| dc.identifier.endpage | 896 | |
| dc.identifier.issn | 1341-9625 | |
| dc.identifier.issn | 1437-7772 | |
| dc.identifier.issue | 5 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 889 | |
| dc.identifier.uri | https://dx.doi.org/10.1007/s10147-013-0636-4 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/2759 | |
| dc.identifier.volume | 19 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Springer | |
| dc.relation.ispartof | International Journal of Clinical Oncology | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/embargoedAccess | |
| dc.subject | Preoperative Chemoradiotherapy | |
| dc.subject | Postoperative Chemoradiotherapy | |
| dc.subject | Stage T3 N0 Rectal Adenocarcinoma | |
| dc.subject | Outcome | |
| dc.title | Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- Yildiz, Ozcan-2014.pdf
- Boyut:
- 428.91 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text











